MEDIUM confidence: 100% data completeness, but the composite (55) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $475 avg across 18 analysts.
Buy-rated share 81% → 82% over ~3 months (+1pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | $2.89 | $3.09 | +6.9% |
| Feb 2026 | $2.31 | $2.46 | +6.5% |
| Nov 2025 | $2.24 | $2.26 | +0.9% |
| Aug 2025 | $1.95 | $2.05 | +5.1% |
| May 2025 | $1.70 | $1.85 | +8.8% |
| Feb 2025 | $1.54 | $1.63 | +5.8% |
| Nov 2024 | $1.64 | $1.67 | +1.8% |
| Aug 2024 | $1.51 | $1.58 | +4.6% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$44.0M over 180 days (0 open-market buys, 88 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $7.3B— | $12.0B+64.2% | $12.3B+2.4% | $9.4B-23.4% | $11.0B+16.9% |
| EPS (dil.) | $3.46— | $5.25+51.7% | $6.55+24.8% | $3.28-49.9% | $4.56+39.0% |
| Free Cash Flow | $2.4B— | $3.8B+57.9% | $3.6B-5.8% | $3.1B-12.2% | $4.3B+37.0% |
| Gross Margin | 66.4% | 65.0%-1.4pp | 64.0%-0.9pp | 57.1%-6.9pp | 61.5%+4.4pp |
| Operating Margin | 23.1% | 27.3%+4.2pp | 31.1%+3.8pp | 21.6%-9.5pp | 26.6%+5.0pp |
| Net Margin | 19.0% | 22.9%+3.9pp | 26.9%+4.1pp | 17.3%-9.6pp | 20.6%+3.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 14.2%/yr (revenue basis).
Base free cash flow $3.7B (avg FY2023–FY2025; latest year $4.3B) · equity value $188.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 55 for Analog Devices indicates a neutral outlook, with the stock's strengths and weaknesses balancing out. The stock scores high on risk, with a relatively low beta and volatility, but is dragged down by its value category, as it trades at a premium with a P/E of 57.3. Momentum is a mixed factor, with a strong 12-month return of 67.6% but a recent 3-month decline of 10.1%, while profitability and growth scores are middling, with ROE near 10% and revenue growth of 16.9%.